Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.

Di Gennaro E, Piro G, Chianese MI, Franco R, Di Cintio A, Moccia T, Luciano A, de Ruggiero I, Bruzzese F, Avallone A, Arra C, Budillon A.

Br J Cancer. 2010 Nov 23;103(11):1680-91. doi: 10.1038/sj.bjc.6605969. Epub 2010 Nov 2.

PMID:
21045833
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.

Nimmagadda S, Shields AF.

Cancer Metastasis Rev. 2008 Dec;27(4):575-87. doi: 10.1007/s10555-008-9148-5. Review.

PMID:
18512023
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design.

El Omari K, Bronckaers A, Liekens S, Pérez-Pérez MJ, Balzarini J, Stammers DK.

Biochem J. 2006 Oct 15;399(2):199-204.

PMID:
16803458
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.

de Bruin M, van Capel T, Van der Born K, Kruyt FA, Fukushima M, Hoekman K, Pinedo HM, Peters GJ.

Br J Cancer. 2003 Mar 24;88(6):957-64.

PMID:
12644837
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.

Haraguchi M, Tsujimoto H, Fukushima M, Higuchi I, Kuribayashi H, Utsumi H, Nakayama A, Hashizume Y, Hirato J, Yoshida H, Hara H, Hamano S, Kawaguchi H, Furukawa T, Miyazono K, Ishikawa F, Toyoshima H, Kaname T, Komatsu M, Chen ZS, Gotanda T, Tachiwada T, Sumizawa T, Miyadera K, Osame M, Yoshida H, Noda T, Yamada Y, Akiyama S.

Mol Cell Biol. 2002 Jul;22(14):5212-21.

PMID:
12077348
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The growth promoting effects of bFGF, PD-ECGF and VEGF on cultured postimplantation rat embryos deprived of serum fractions.

Ulger H, Karabulut AK, Pratten MK.

J Anat. 2000 Aug;197 ( Pt 2):207-19.

PMID:
11005713
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prognostic significance of angiogenesis in human pancreatic cancer.

Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M.

Br J Cancer. 1999 Mar;79(9-10):1553-63.

PMID:
10188906
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.

Stevenson DP, Collins WP, Farzaneh F, Hata K, Miyazaki K.

Am J Pathol. 1998 Nov;153(5):1573-8.

PMID:
9811349
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

Brown NS, Bicknell R.

Biochem J. 1998 Aug 15;334 ( Pt 1):1-8. Review.

PMID:
9693094
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

Koukourakis MI, Giatromanolaki A, Kakolyris S, O'Byrne KJ, Apostolikas N, Skarlatos J, Gatter KC, Harris AL.

Br J Cancer. 1998 May;77(10):1696-703.

PMID:
9635852
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.

Griffiths L, Stratford IJ.

Br J Cancer. 1997;76(6):689-93. Review.

PMID:
9310231
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC, Harris AL.

Br J Cancer. 1997;75(4):477-81.

PMID:
9052396
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.

Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y, Sowa M.

Br J Cancer. 1996 Apr;73(8):884-8.

PMID:
8611421
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.

Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC, Harris AL.

Br J Cancer. 1996 Feb;73(3):275-80.

PMID:
8562330
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.

Heldin NE, Usuki K, Bergh J, Westermark B, Heldin CH.

Br J Cancer. 1993 Oct;68(4):708-11.

PMID:
8398697
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Tumour vasculature--a potential therapeutic target.

Baillie CT, Winslet MC, Bradley NJ.

Br J Cancer. 1995 Aug;72(2):257-67. Review.

PMID:
7543770
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Thymidine phosphorylase is angiogenic and promotes tumor growth.

Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R.

Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):998-1002.

PMID:
7532308
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Structural and functional studies on platelet-derived growth factor.

Heldin CH.

EMBO J. 1992 Dec;11(12):4251-9. Review. No abstract available.

PMID:
1425569
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk